Jeanne M. Quivey, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jeanne M. Quivey, MD

Professor, Department of Radiation Oncology, UCSF
Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professorship in Head and Neck Cancer Radiation Oncology, UCSF

Phone: (415) 353-9807 (appts)
Box 1708, UCSF
San Francisco, CA 94143-1708

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Breast Oncology

Education

University of California, Berkeley, CA, BA, 1966, Genetics
University of California San Francisco, CA, MD, 1970, Medicine


Professional Experience

  • 1970-1971
    Intern, Highland-Alameda County Hospital, Oakland, CA
  • 1971-1974
    Resident, Division of Radiation Oncology, University of California San Francisco, CA
  • 1974
    Chief Resident, Divsion of Radiation Oncology, University of California San Francisco, CA
  • 1974-1975
    Clinical Instructor, Division of Radiation Oncology, Department of Radiology, University of California San Francisco, CA
  • 1975-1981
    Assistant Clinical Professor, Department Radiation Oncology, University of California San Francisco, CA
  • 1977-1981
    Guest Scientist, Lawrence Berkeley Laboratory, Berkeley, CA
  • 1981-1988
    Associate Clinical Professor, Department of Radiation Oncology, University of California San Francisco, CA
  • 1981-1986
    Associate Staff Radiotherapist, Ralph K. Davies Medical Center, San Francisco, CA
  • 1988-1990
    Associate Professor of Clinical Radiation Oncology, Department of Radiation Oncology, University of California San Francisco, CA
  • 1990-present
    Professor of Clinical Radiation Oncology, Department of Radiation Oncology, University of California San Francisco, CA

Selected Publications

  1. In Reply to Kamrava and McCannel. Int J Radiat Oncol Biol Phys. 2015 Sep 1; 93(1):216-7.
    View on PubMed
  2. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma. Int J Radiat Oncol Biol Phys. 2015 Jun 1; 92(2):376-83.
    View on PubMed
  3. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014; 9:269.
    View on PubMed
  4. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):330-6.
    View on PubMed
  5. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 1; 77(3):707-14.
    View on PubMed
  6. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009 Aug 1; 27(22):3684-90.
    View on PubMed
  7. Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys. 2009 Feb 1; 73(2):578-84.
    View on PubMed
  8. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol. 2009 Feb; 90(2):213-20.
    View on PubMed
  9. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer. 2008 Aug 1; 113(3):497-507.
    View on PubMed
  10. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007 Dec 1; 69(5):1625-33.
    View on PubMed
  11. Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract. 2007 Nov-Dec; 13(7):750-7.
    View on PubMed
  12. Detection of treatment setup errors between two CT scans for patients with head and neck cancer. Med Phys. 2007 Aug; 34(8):3233-42.
    View on PubMed
  13. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys. 2007 Sep 1; 69(1):141-7.
    View on PubMed
  14. Simplifying intensity-modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma. J Appl Clin Med Phys. 2007; 8(2):26-36.
    View on PubMed
  15. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 1; 68(3):809-16.
    View on PubMed
  16. Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1031-5.
    View on PubMed
  17. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):138-43.
    View on PubMed
  18. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1044-50.
    View on PubMed
  19. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):152-9.
    View on PubMed
  20. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64(2):355-62.
    View on PubMed

Go to UCSF Profiles, powered by CTSI